Cargando…
Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma
BACKGROUND: Autoantibodies against tumor associated antigens are highly related to cancer progression. Autoantibodies could serve as indicators of tumor burden, and have the potential to monitor the response of treatment and tumor recurrence. However, how the autoantibody repertoire changes in respo...
Autores principales: | Li, Yang, Li, Cheng-qiang, Guo, Shu-juan, Guo, Wei, Jiang, He-wei, Li, He-cheng, Tao, Sheng-ce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047177/ https://www.ncbi.nlm.nih.gov/pubmed/32113159 http://dx.doi.org/10.1016/j.ebiom.2020.102674 |
Ejemplares similares
-
Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018) -
Autoantibody Profiling of Glioma Serum Samples to Identify Biomarkers Using Human Proteome Arrays
por: Syed, Parvez, et al.
Publicado: (2015) -
Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients
por: Tan, Qiaoyun, et al.
Publicado: (2020) -
Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2017) -
Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma
por: Lin, Lie-Hao, et al.
Publicado: (2017)